leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe

RxCUI: 752889
RxNorm name: leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe
Display name: leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe
Full name: leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Vabrinty	LEUPROLIDE ACETATE	URONOVA PHARMACEUTICALS, INC.	008776cc-83f1-4f8c-819b-6471425da15f	2026-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 752889
Eligard	LEUPROLIDE ACETATE	TOLMAR Inc.	b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	2026-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 752889
ELIGARD	LEUPROLIDE ACETATE	TOLMAR Inc.	b78d1919-9dee-44fa-90f9-e0a26d32481d	2019-04-29	Warnings, Adverse reactions	Exact identifier rxcui: 752889

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
b78d1919-9dee-44fa-90f9-e0a26d32481d	leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe [PSN] · 0.5 ML leuprolide acetate 60 MG/ML Prefilled Syringe [SCD] · leuprolide acetate 30 MG per 0.5 ML (4 month) Prefilled Syringe [SY]	3	51	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD ® . ELIGARD ® (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20190429
b7b679a9-6823-4ef8-8d31-3ab5058ffcfc	leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe [PSN] · 0.5 ML leuprolide acetate 60 MG/ML Prefilled Syringe [SCD] · leuprolide acetate 30 MG per 0.5 ML (4 month) Prefilled Syringe [SY]	3	19	These highlights do not include all the information needed to use ELIGARD ® safely and effectively. See full prescribing information for ELIGARD. ELIGARD (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20260430
008776cc-83f1-4f8c-819b-6471425da15f	leuprolide acetate 30 MG in 0.5 ML (4 month) Prefilled Syringe [PSN] · 0.5 ML leuprolide acetate 60 MG/ML Prefilled Syringe [SCD] · leuprolide acetate 30 MG per 0.5 ML (4 month) Prefilled Syringe [SY]	3	9	These highlights do not include all the information needed to use VABRINTY™ safely and effectively. See full prescribing information for VABRINTY. VABRINTY (leuprolide acetate) for injectable suspension, for subcutaneous use Initial U.S. Approval: 2002	20250601